"}

Gefapixant - Moligand™, 10mM in DMSO , Antagonist of P2X3, CAS No.1015787-98-0, Antagonist of P2X3

Disponible
SKU
G420321
Elementos de artículos agrupados
Nombre del producto Cantidad
[G420321-1ml] Gefapixant
Special Price 100,57 € Regular Price 117,93 €

P2 Receptor Antagonists

Information

Gefapixant Gefapixant (AF-219, MK-7264, R1646, RG-1646, RO 4926219) is an orally active small molecule antagonist of human P2X3 receptor with IC50 of about 30 nM, 100–250 nM for recombinant hP2X3 homotrimers and hP2X2/3 heterotrimeric receptors , respectively. Gefapixant has shown promise for the treatment of refractory and unexplained chronic cough.

Targets

hP2X3 (Cell-free assay); hP2X2/3 (Cell-free assay) 30 nM; 100-250 nM

Más Información

Más Información
CAS1015787-98-0
Concentración10mM in DMSO
Sinónimos5-[(2,4-Diamino-5-pyrimidinyl)oxy]-4-isopropyl-2-methoxybenzenesulfonamide | AF9 | Lopac0_000838 | DB15097 | AC-35643 | Benzenesulfonamide, 5-[(2,4-diamino-5-pyrimidinyl)oxy]-2-methoxy-4-(1-methylethyl)- | s6664 | Tox21_303065 | Gefapixant(AF-219,MK-7264)
Especificaciones y purezaMoligand™, 10mM in DMSO
Condiciones de almacenamiento de almacenamientoStore at -80°C
Enviado enDry ice packs + Cold packs
Product Description

Information

Gefapixant Gefapixant (AF-219, MK-7264, R1646, RG-1646, RO 4926219) is an orally active small molecule antagonist of human P2X3 receptor with IC50 of about 30 nM, 100–250 nM for recombinant hP2X3 homotrimers and hP2X2/3 heterotrimeric receptors , respectively. Gefapixant has shown promise for the treatment of refractory and unexplained chronic cough.

Targets

hP2X3 (Cell-free assay); hP2X2/3 (Cell-free assay) 30 nM; 100-250 nM

Pubchem Sid528772219
ObjetivoP2RX3
Número CE823-334-6
PubChem CID24764487
Fórmula molecularC14H19N5O4S

Reseñas

Reseñas de cliente

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.

Copyright © 2023-present Aladdin Scientific Corp All rights reserved.